University of California San Francisco UCSF Medical CenterUCSF Department of SurgeryUCSF School of Medicine
  
Surgery Websites
  • Faculty

  • Conditions & Procedures

  • Education & Training

    • GI/Bariatric Fellowship

    • Program Description
    • Clinical Fellows
  • Patient Center

    • Appointments & Referrals

    • Location & Directions
    • Request an Appointment
    • Refer a Patient
    • Gastrointestinal Surgery at UCSF

    • Why UCSF for GI Surgery?
    • Clinical Trials

  • Research

    • Clinical Trials
  • News & Events

Gastrointestinal Surgery »  Conditions & Procedures »  Borderline Resectable Pancreatic Cancer (BRPC)

Borderline Resectable Pancreatic Cancer (BRPC)

Pancreatic ductal adenocarcinoma (PDAC) is the third most common cause of cancer-related mortality in the United States with 41,780 projected deaths in 2016, and is expected to rise to the second leading cause by 2030. This malignancy is characteristically highly aggressive and treatment-resistant, with nearly 80% of PDAC patients presenting with either metastatic or inoperable disease at the time of diagnosis. The minority of patients with localized, non-metastatic disease who are potential surgical candidates may be divided into two categories: 

  • Those who have clearly resectable disease at initial diagnosis
  • Those with borderline resectable pancreatic cancer (BRPC)

BRPC represents an increasingly recognized, distinct clinical entity characterized by primary tumor involving surrounding vasculature with a high risk for margin-positive resection if resected de novo — that is, surgically removed in newly diagnosed patients. 

Treatment Options

Neoadjuvant therapy (treatment before surgery) is often considered for patients with both resectable and borderline resectable disease. While the most common treatment paradigm for patients with clearly resectable tumors entails immediate surgery followed by adjuvant therapy (treatment post-surgery), neoadjuvant strategies in this context may be helpful to eradicate any micrometastatic disease and to identify suitable candidates most likely to benefit from surgery.

Select studies have explored this paradigm in patients with up-front resectable disease, with promising results. Meanwhile, administration of neoadjuvant therapy for patients with BRPC is also recommended to improve the likelihood of margin-negative (R0) resection, a significant prognostic indicator for long-term survival or cure. 


The following is syndicated content from the National Cancer Institute (NCI)

Clinics & Appointments

Gastrointestinal Surgery at Parnassus

400 Parnassus Ave.
2nd Floor
San Francisco, CA 94143

(415) 353-2161 Front Desk
(415) 353-2804 New Patients
(415) 353-2161 Follow-Up Appts.
(415) 353-2505 Fax

Hours: Monday thru Friday
8 a.m. – 5 p.m

Maps, Directions & Parking
Request an Appointment
Refer a Patient

Gastrointestinal Surgery at Parnassus

400 Parnassus Ave., 2nd Floor
San Francisco, CA 94143 

Google Map & Directions
Campus & Parking Map
Multi-Lingual Driving Directions
Directions by UCSF Destination
UCSF Medical Center Patient Info

Clinical Team

  • Hobart W. Harris, M.D., M.P.H.Gastrointestinal Surgeon

Related Conditions & Procedures

  • Distal Pancreatectomy
  • Whipple Procedure (Pancreaticoduodenectomy)

Related News

  • Surgery Now a Realistic Option for More Patients with Pancreatic Cancer
  • Surgical & Therapeutic Advances in Pancreatic Cancer
 
Related Sites & Labs
  • Bariatric Surgery
  • Colorectal Surgery
  • Endocrine Surgery
  • General Surgery
  • Melanoma Surgery
  • Thoracic Oncology Lab
  • Transplant Surgery
  • Zuckerberg San Francisco General
  • San Francisco VA Medical Center
 
Site Directory
  • Web Support Portal
  • Surgery Staff Portal
  • CLINICAL WEBSITES
  • Acute Care Surgery
  • Cardiothoracic Surgery
  • Bariatric Surgery
  • Breast Care Surgery
  • Cardiac Surgery
  • Center for Hernia Repair & Abdominal Wall Reconstruction
  • Center for Limb Preservation and Diabetic Foot
  • Center for Surgery in Older Adults
  • Colorectal Surgery
  • Endocrine Surgery
  • Enhanced Recovery After Surgery (ERAS)
  • Gastrointestinal Surgery
  • General Surgery
  • Hepatobiliary & Pancreatic Surgery
  • LiverSource
  • Melanoma Surgery
  • Ostomy Education Portal
  • Pediatric Cardiothoracic Surgery
  • Pediatric Surgery
  • Plastic & Reconstructive Surgery
  • Robotic Surgery
  • San Francisco VA Medical Center
  • Thoracic Oncology Program
  • Thoracic Surgery
  • Transplant Surgery
  • UCSF East Bay Surgery Program
  • Vascular & Endovascular Surgery
  • Zuckerberg San Francisco General
  • EDUCATION AND TRAINING
  • Abdominal Transplant Fellowship
  • Faculty Affairs & Development Portal
  • Medical Student Portal
  • Muriel Steele Society
  • Plastic Surgery Residency
  • Resident Portal
  • Resident Research
  • Surgical & Critical Care NP Fellowship
  • Surgery Education Portal
  • Surgery Research Portal
  • Surgical Skills Center
  • Thoracic Surgery Residency
  • T32 Surgical Oncology
  • T32 Research Training in Transplant Surgery
  • Vascular Surgery Integrated Residency
  • RESEARCH WEBSITES
  • Atherosclerosis Research Lab
  • Biostatistics Core
  • Cardiac Biomechanics Lab
  • Center for Global Surgery and Health Equity
  • Center for Mindfulness in Surgery
  • Chang Laboratory for Liver Tissue Engineering
  • Conte Lab
  • Endocrine Neoplasia Research Lab
  • Immunogenetics & Transplantation Lab
  • Kornblith Lab
  • Kratz Lab
  • Lobular Breast Cancer Research Program
  • MacKenzie Lab
  • Nijagal Lab
  • Pediatric Surgery Lab
  • Pomerantz Lab
  • San Francisco Wraparound Project
  • Sarwal Lab
  • Surgical Innovations
  • Warren Lab in Surgical Oncology
  • Tang Lab
  • Thoracic Oncology Lab
  • Transplantation Research Lab
  • TSI Lab
  • Wang Lab
  • Weaver Lab
  • Willenbring Lab
  • RESOURCES
  • Scientific Publications Office
    © 2024 The Regents of the University of California. 
    Terms of Use | Report a Problem
    Site Developer: Jason Powers; Web Manager, Rob Mayfield; Engineer, Digital Strategies